MoneyWorks4Me

Acutaas Chemicals - Quaterly Results

01 May 2026 Evaluate
The sales surged to Rs. 4217.72 millions, up 38.67% for the March 2026 quarter as against Rs. 3041.61 millions during the corresponding quarter previous year.The Net Profit of the company vaulted to 118.10% to Rs. 1370.71  millions from Rs. 628.48 millions in the previous quarter.Operating Profit saw a handsome growth to 1957.63 millions from 897.52 millions in the quarter ended March 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 4217.72 3041.61 38.67 13237.92 9898.35 33.74 13237.92 9898.35 33.74
Other Income 145.46 56.94 155.46 458.78 183.36 150.21 458.78 183.36 150.21
PBIDT 1957.63 897.52 118.12 5288.83 2434.78 117.22 5288.83 2434.78 117.22
Interest 10.72 3.83 179.90 30.77 58.57 -47.46 30.77 58.57 -47.46
PBDT 1946.91 893.69 117.85 5258.06 2376.21 121.28 5258.06 2376.21 121.28
Depreciation 88.30 65.56 34.69 330.32 240.45 37.38 330.32 240.45 37.38
PBT 1858.61 828.13 124.43 4927.74 2135.76 130.73 4927.74 2135.76 130.73
TAX 487.90 199.65 144.38 1265.99 540.29 134.32 1265.99 540.29 134.32
Deferred Tax 17.36 47.36 -63.34 111.09 70.58 57.40 111.09 70.58 57.40
PAT 1370.71 628.48 118.10 3661.75 1595.47 129.51 3661.75 1595.47 129.51
Equity 409.36 409.34 0.00 409.36 409.34 0.00 409.36 409.34 0.00
PBIDTM(%) 46.41 29.51 57.29 39.95 24.60 62.42 39.95 24.60 62.42
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..